Introduction Attention-deficit/hyperactivity disorder (ADHD) was originally treated as a neurodevelopmental that occurs mainly in children and tends to diminish or disappear with age, but we now know symptoms persist into adulthood over 50% of ADHD patients. Undiagnosed individuals often turn psychoactive substance minimize the negative aspects functioning improve quality life. Methods The stud...

KEY FINDINGS Data from the National Ambulatory Medical Care Survey •During 2012-2013, an estimated annual average of 6.1 million physician office visits were made by children aged 4-17 years with a primary diagnosis of attention-deficit/hyperactivity disorder (ADHD). •The ADHD visit rate among children aged 4-17 years was more than twice as high for boys (147 per 1,000 boys) as for girls (62 pe...

how to cite this article: fayyazi a, khajeh a. does electroencephalography contribute to examining children with attention deficit hyperactivity disorder? iran j child neurol. 2014 summer;8(3): 65-67. letter to editor, has not abstract. references swaiman kenneth f as, ferriero d, schor n. pediatric neurology: principles & practice. 5th ed. philadelphia: elsevier/saunders; 2012. p.622-628. sado...

We describe the first invertebrate model of attention deficit hyperactivity disorder (ADHD) that reproduces its major features, including hyperactivity, male predominance, marked exacerbation by simple carbohydrates, reversible response to dextroamphetamine, and a "paradoxical response" to stimulants. This model may offer new insight into ADHD pathogenesis and treatment. Furthermore, these find...

The purpose of this study was to examine two executive control processes--response inhibition and re-engagement of responses after inhibition in children with attention deficit hyperactivity disorder (ADHD). Thirty-three children with ADHD and 22 normal control children of similar age (7 to 11 years) and mean IQ (107) were tested with the change paradigm. ADHD subgroups were defined by the cont...

AIM To test the efficacy and safety of osmotic release oral system (OROS) methylphenidate (MPH) in doses up to 180 mg/day to treat attention deficit hyperactivity disorder (ADHD) and prevent any drug relapse in individuals with a co-diagnosis of ADHD and amphetamine dependence. DESIGN Randomized placebo-controlled 24-week double-blind trial with parallel groups design. SETTING Participants ...

the present study aimed to investigating the effect of using parental behavioral training for mothers on reducing hyperactivity symptoms and rule-breaking behaviors of their 9-11 year old children with attention deficit hyperactivity disorder. the research design was quasi-experimental with pre-test and posttest and control groups. to do so, 30 mothers of children with adhd (hyperactivity-impul...

AIM The present study aimed to compare cognitive signs of bipolar disorder patients with that of adult attention-deficit/hyperactivity disorder (ADHD) patients. METHOD The study comprised 66 bipolar disorder patients, 63 ADHD patients, and 58 healthy controls.Structured Clinical Interview for DSM-IV Axis-I Disorders (SCID-I), Wender Utah Rating Scale, and Adult Attention-Deficit/Hyperactivity...

The aim of this study is the normalization of the Wender Utah rating scale which is used to detect adults with Attention-Deficit and Hyperactivity Disorder (ADHD). Available sampling method was used to choose 400 parents of children (200 parents of children with ADHD as compared to 200 parents of normal children). Wender Utah rating scale, which has been designed to diagnose ADHD in adults, is ...